Skip to main content
Clinical Trials/JPRN-UMIN000053399
JPRN-UMIN000053399
Recruiting
未知

Analysis of human genetic factors determining anti-HBV immune response to HBV reactivation or HB vaccine after allogeneic hematopoietic cell transplantation - HBV response

Japan Agency for Medical Research and Development0 sites43 target enrollmentJanuary 20, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
hematological malignancies
Sponsor
Japan Agency for Medical Research and Development
Enrollment
43
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2024
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials